Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Assets Average (2016 - 2025)

Historic Assets Average for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $170.7 million.

  • Fortress Biotech's Assets Average rose 2512.45% to $170.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $170.7 million, marking a year-over-year increase of 2512.45%. This contributed to the annual value of $155.9 million for FY2024, which is 3249.66% down from last year.
  • Per Fortress Biotech's latest filing, its Assets Average stood at $170.7 million for Q3 2025, which was up 2512.45% from $169.0 million recorded in Q2 2025.
  • Fortress Biotech's 5-year Assets Average high stood at $413.0 million for Q3 2021, and its period low was $135.7 million during Q4 2024.
  • In the last 5 years, Fortress Biotech's Assets Average had a median value of $222.1 million in 2023 and averaged $260.1 million.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 6270.84% in 2021, then crashed by 5181.67% in 2023.
  • Quarter analysis of 5 years shows Fortress Biotech's Assets Average stood at $402.2 million in 2021, then dropped by 23.18% to $308.9 million in 2022, then plummeted by 48.52% to $159.0 million in 2023, then decreased by 14.7% to $135.7 million in 2024, then rose by 25.8% to $170.7 million in 2025.
  • Its last three reported values are $170.7 million in Q3 2025, $169.0 million for Q2 2025, and $161.1 million during Q1 2025.